drugset / Trial / NCT00182884

Donepezil in Preventing Delirium in Hospitalized Elderly

NCT00182884

Phase 4 Completed 30 enrolled Indiana University Health
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to explore the efficacy of a perioperative daily dose of Donepezil (a cholinergic enhancer) in reducing the incidence and severity of delirium.

Timeline

Start
2004-07
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications